Parkinson's disease

Compr Ther. 1986 Mar;12(3):25-9.
No abstract available

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Amantadine / therapeutic use
  • Animals
  • Benserazide / therapeutic use
  • Carbidopa / therapeutic use
  • Drug Therapy, Combination
  • Dyskinesia, Drug-Induced / etiology
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / adverse effects
  • Levodopa / therapeutic use
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Parasympatholytics / therapeutic use
  • Parkinson Disease* / drug therapy*
  • Parkinson Disease* / etiology
  • Parkinson Disease* / pathology
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / drug therapy
  • Pyridines / poisoning
  • Rats

Substances

  • Monoamine Oxidase Inhibitors
  • Parasympatholytics
  • Pyridines
  • Levodopa
  • Benserazide
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Amantadine
  • Carbidopa